Related references
Note: Only part of the references are listed.The biosynthetic gene cluster of zorbamycin, a member of the bleomycin family of antitumor antibiotics, from Streptomyces flavoviridis ATCC 21892
Ute Galm et al.
MOLECULAR BIOSYSTEMS (2009)
Crystal structure of DNA-bound Co(III)-bleomycin B2:: Insights on intercalation and minor groove binding
Kristie D. Goodwin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The tallysomycin biosynthetic gene cluster from Streptoalloteichus hindustanus E465-94 ATCC 31158 unveiling new insights into the biosynthesis of the bleomycin family of antitumor antibiotics
Meifeng Tao et al.
MOLECULAR BIOSYSTEMS (2007)
Assessment of the safety and pharmacokinetics of anidulafungin when administered with cyclosporine
JA Dowell et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Solid-phase synthesis of bleomycin group antibiotics. construction of a 108-member deglycobleomycin library
CJ Leitheiser et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin
B Gust et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Total syntheses of (+)-zampanolide and (+)-dactylolide exploiting a unified strategy
AB Smith et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Studies toward the synthesis of (-)-zampanolide:: Preparation of N-acyl hemiaminal model systems
DM Troast et al.
ORGANIC LETTERS (2002)
Cloning and characterization of the bleomycin biosynthetic gene cluster from Streptomyces verticillus ATCC15003
B Shen et al.
JOURNAL OF NATURAL PRODUCTS (2002)
A continuous assay for DNA cleavage: The application of break lights to enediynes, iron-dependent agents, and nucleases
JB Biggins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Bleomycin: New perspectives on the mechanism of action
SM Hecht
JOURNAL OF NATURAL PRODUCTS (2000)
In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi
S Tawara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
